Advancements in NASH Therapy: Exploring the New Wave of Drug Classes
  Non-alcoholic steatohepatitis (NASH) is a chronic liver disease marked by inflammation, fat accumulation, and liver damage, often progressing to cirrhosis or liver failure. As the global prevalence of NASH rises, effective NASH treatment options remain limited, creating an urgent need for novel therapies. The NASH pipeline is currently filled with promising drug classes that could...
0 Komen 0 Perkongsian 68 Views 0 review
adstera